Nils Danielsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nils Danielsen has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Cecilia Eriksson Linsmeier
Neuronano Research Center, BMC F10, Lund University, SE-221 84 Lund, Sweden
1 shared publication - Christelle N. Prinz
Department of Physics, Division of Solid State Physics, Lund University, Lund, Sweden, Sweden
1 shared publication - Jens Schouenborg
Neuronano Research Center, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden
1 shared publication - Lina Gällentoft
Department of Experimental Medical Science, Medical Faculty, Neuronano Research Center (NRC), Lund University, Lund, Sweden
1 shared publication - Lina M. E. Pettersson
Neuronano Research Center, Department of Experimental Medicine, Lund University, Lund, Sweden; NanoLund, Lund University, Professorsgatan 1, SE-223 63, Lund, Sweden
1 shared publication
Latest Publications
- Open Access
- 9 August 2016
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 14 (1) , 1-11
Impact of degradable nanowires on long-term brain tissue responses
A promising approach to improve the performance of neural implants consists of adding nanomaterials, such as nanowires, to the surface of the implant. Nanostructured interfaces could improve the integration and communication stability, partly through the reduction of the cell-to-electrode distance. However, the safety issues of implanted nanowires in the brain need to be evaluated and understood before nanowires can be used on the surface of implants for long periods of time. To this end we here investigate whether implanted degradable nanowires offer any advantage over non-degradable nanowires in a long-term in vivo study (1 year) with respect to brain tissue responses. The tissue response after injection of degradable silicon oxide (SiOx)-coated gallium phosphide nanowires and biostable hafnium oxide-coated GaP nanowires into the rat striatum was compared. One year after nanowire injection, no significant difference in microglial or astrocytic response, as measured by staining for ED1 and glial fibrillary acidic protein, respectively, or in neuronal density, as measured by staining for NeuN, was found between degradable and biostable nanowires. Of the cells investigated, only microglia cells had engulfed the nanowires. The SiOx-coated nanowire residues were primarily seen in aggregated hypertrophic ED1-positive cells, possibly microglial cells that have fused to create multinucleated giant cells. Occasionally, degradable nanowires with an apparently intact shape were found inside single, small ED1-positive cells. The biostable nanowires were found intact in microglia cells of both phenotypes described. The present study shows that the degradable nanowires remain at least partly in the brain over long time periods, i.e. 1 year; however, no obvious bio-safety issues for this degradable nanomaterial could be detected.
- 9 August 2016
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 14 (1) , 1-11
Open AccessImpact of degradable nanowires on long-term brain tissue responses
A promising approach to improve the performance of neural implants consists of adding nanomaterials, such as nanowires, to the surface of the implant. Nanostructured interfaces could improve the integration and communication stability, partly through the reduction of the cell-to-electrode distance. However, the safety issues of implanted nanowires in the brain need to be evaluated and understood before nanowires can be used on the surface of implants for long periods of time. To this end we here investigate whether implanted degradable nanowires offer any advantage over non-degradable nanowires in a long-term in vivo study (1 year) with respect to brain tissue responses. The tissue response after injection of degradable silicon oxide (SiOx)-coated gallium phosphide nanowires and biostable hafnium oxide-coated GaP nanowires into the rat striatum was compared. One year after nanowire injection, no significant difference in microglial or astrocytic response, as measured by staining for ED1 and glial fibrillary acidic protein, respectively, or in neuronal density, as measured by staining for NeuN, was found between degradable and biostable nanowires. Of the cells investigated, only microglia cells had engulfed the nanowires. The SiOx-coated nanowire residues were primarily seen in aggregated hypertrophic ED1-positive cells, possibly microglial cells that have fused to create multinucleated giant cells. Occasionally, degradable nanowires with an apparently intact shape were found inside single, small ED1-positive cells. The biostable nanowires were found intact in microglia cells of both phenotypes described. The present study shows that the degradable nanowires remain at least partly in the brain over long time periods, i.e. 1 year; however, no obvious bio-safety issues for this degradable nanomaterial could be detected.